ONCOSEC MEDICAL Inc 4

4 · ONCOSEC MEDICAL Inc · Filed Dec 16, 2016

Form 4

Period: 2016-12-14

Chief Legal Officer

Transactions

Disposition to Issuer
Employee Stock Option (right to buy)
2016-12-14−6,250→ 0 total
Exercise: $7.60Exp: 2025-03-03→ Common Stock (6,250 underlying)
Disposition to Issuer
Employee Stock Option (right to buy)
2016-12-14−10,000→ 0 total
Exercise: $8.80Exp: 2024-12-16→ Common Stock (10,000 underlying)
Disposition to Issuer
Employee Stock Option (right to buy)
2016-12-14−74,000→ 0 total
Exercise: $5.76Exp: 2025-08-21→ Common Stock (74,000 underlying)
Award
Employee Stock Option (right to buy)
2016-12-14+45,125→ 45,125 total
Exercise: $1.29Exp: 2026-12-14→ Common Stock (45,125 underlying)

Footnotes (6)

[F1]These stock options were granted as Incentive Stock Options only to the extent that the $100,000 dollar limitation of 26 U.S.C. ss.422(d) is not exceeded; anything beyond that is deemed a Non-qualified Stock Option.
[F2]The stock options were scheduled to fully vest on December 16, 2017, the third anniversary of the grant date.
[F3]On December 14, 2016, OncoSec Medical Incorporated cancelled, pursuant to its option exchange program, options for 10000 shares (previously granted on December 16, 2014), 6250 shares (previously granted on March 3, 2015) and 74000 shares (previously granted on August 21,2015) of common stock. In exchange, and subject to the terms of the Stock Option Exchange Program, the reporting person received a replacement option for 45125 shares of common stock with an exercise price of $1.29 per share.
[F4]The stock options were scheduled to fully vest on March 3, 2018, the third anniversary of the grant date.
[F5]The stock options were scheduled to fully vest on August 21, 2018, the third anniversary of the grant date.
[F6]The stock options granted on December 14, 2016 will vest on the following schedule: 25% on grant date; 1/36th of the remaining 75% vesting on each of the 36 subsequent monthly anniversaries of the grant date.

Documents

1 file